ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Direxion Daily Biotech Top 5 Bull 2X ETF
38.29
-1.0161
-2.59%
盤後:
38.29
0.0000
0.00%
16:10 EDT
成交量:
1.70萬
成交額:
65.82萬
市值:
287.17萬
市盈率:
- -
高:
38.92
開:
38.30
低:
38.23
收:
39.31
52周最高:
45.88
52周最低:
25.71
股本:
7.50萬
流通股本:
7.50萬
量比:
1.08
換手率:
22.73%
股息:
0.62
股息率:
1.62%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
高盛9月「確信名單」更新:美股納入福泰製藥 歐股力推萊茵、Adyen和塔蘭克斯
智通财经
·
09/02
英國監管機構因數據不可靠,暫停安進公司Tavneos用於新患者
路透中文
·
09/01
英國藥品與健康產品管理局:通知上市許可持有方,自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor
美股速递
·
09/01
特朗普政府將宣佈藥品定價協議
路透中文
·
09/01
機構:爭奪天然氣資產推高併購交易規模創2013年以來新高
智通财经
·
08/31
安進(AMGN)降脂藥Repatha新臨床數據:可降低未發生心梗或中風高危患者20%死亡風險
金吾财讯
·
08/31
南京諾令生物科技股份有限公司向港交所提交上市申請書,獨家保薦人為建銀國際。
智通财经
·
08/28
據港交所文件,維眸生物科技股份有限公司-B向港交所提交上市申請書。
智通财经
·
08/28
美國食品藥品監督管理局(FDA)批准吉利德治療艾滋病的每日一次複方片劑
路透中文
·
08/28
美國FDA批准吉利德科學Bixlenvo™上市:每日單片方案為病毒學抑制HIV成人患者提供新選擇,涵蓋複雜治療方案人群
美股速递
·
08/28
英國股市——8月27日需關注的因素
路透中文
·
08/27
阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標
路透中文
·
08/27
Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果,共同主要終點及所有關鍵次要終點全面達標
美股速递
·
08/27
美股開盤|三大指數升跌不一;Meta升逾3%、小鵬汽車升逾3%;生物科技股活躍
美股开盘
·
08/26
羅兵咸永道:上半年中國併購交易量7316宗創歷史新高 預計下半年延續強勁勢頭
智通财经
·
08/25
歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍,覆蓋所有PD-L1狀態
美股速递
·
08/24
吉利德科學:歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌
美股速递
·
08/24
美國聯邦貿易委員會(FTC):安進專利申請收購交易受到反壟斷審查。
智通财经
·
08/21
Piper Sandler上調安進目標價至457美元
格隆汇
·
08/21
美國研究綜述-安進、Analog Devices、莫德納
路透中文
·
08/20
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/TBXU/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":38.289,"timestamp":1789502400000,"preClose":39.3051,"halted":0,"volume":17045,"hourTrading":{"tag":"盘后","latestPrice":38.289,"preClose":38.289,"latestTime":"16:10 EDT","volume":6,"amount":229.55597999999998,"timestamp":1789503007596,"change":0,"changeRate":0,"amplitude":0.002324},"delay":0,"changeRate":-0.025851607043360824,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"盤後交易","change":-1.0161,"latestTime":"09-15 16:50:49 EDT","open":38.3,"high":38.92,"low":38.225,"amount":658181,"amplitude":0.017682,"askPrice":50.56,"askSize":10,"bidPrice":19.37,"bidSize":200,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":39.3051,"sharesOutstanding":100001,"nav":38.336,"aum":2875239.83,"dividendRate":0.01624,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.289,"preClose":38.289,"latestTime":"16:10 EDT","volume":6,"amount":229.55597999999998,"timestamp":1789503007596,"change":0,"changeRate":0,"amplitude":0.002324},"volumeRatio":1.076168},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.076168,"shares":75001,"dividePrice":0.6218,"high":38.92,"amplitude":0.017682,"preClose":39.3051,"low":38.225,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":38.289,"committee":0.904762,"eps":0,"divideRate":0.01624,"volume":17045,"delay":0,"ttmEps":0,"open":38.3,"prevYearClose":31.065,"prevWeekClose":38.3601,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":40.6496,"twentyDayClose":40.3209,"sixtyDayClose":29.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664891705","title":"高盛9月「確信名單」更新:美股納入福泰製藥 歐股力推萊茵、Adyen和塔蘭克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891705","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891705?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":"进入秋季,高盛对其美国及欧洲市场的“确信名单”进行了更新,为投资者指明当前最看好的股票方向。本次调整中,美国名单新增一只大型生物科技股,欧洲名单则迎来三家新面孔。美国名单:新增福泰制药,移除盈透证券在美国市场,高盛将 $福泰制药$纳入确信名单,同时移除了 $盈透证券$,调整后名单保留23只股票。高盛还表示,塔兰克斯的国际零售业务是被低估的增长引擎。","market":"us","thumbnail":"https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490866.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0004091025.USD","IBKR","LU2362541273.HKD","VRTX","LU0432979614.USD","GSX","LU0109394709.USD","IE0002270589.USD","GNMX","LU2265009873.SGD","LU1069344957.HKD","LU2471134523.USD","BIB","LU2471134796.USD","LU2456880835.USD","LU0106831901.USD","VGK","IE00B2B36J28.USD","MSFL","IDNA","BBH","LU2417539215.USD","LU1868837136.USD","PBE","UNHW","BK4585","EL","UN","MSFD","LU2468319806.SGD","BK4532","IE00BJT1NW94.SGD","MSFC","MSFU","MSFW","IE00BFTCPJ56.SGD","COP","WFC","SG9999001176.SGD","LU2471134952.CNY","BK4533","LU1868836757.USD","TBXU","LU0889565916.HKD","SG9999001176.USD","XYZY","XYZ","LU1585245621.USD","XYZG","LU2237443549.SGD","UNHG","LU2236285917.USD","MSFY","MSFX","IE0034235188.USD","IEV","UNHU","UNH","IBB","IE00BFXG1179.USD","CRNX","DAL","BK4567","IBBQ","LU0345770993.USD","IE00B19Z3581.USD","VXUS","LU2471134879.HKD","LU1868837300.USD","MSFO","MSFT","BK4504","LU2750360641.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664347855","title":"英國監管機構因數據不可靠,暫停安進公司Tavneos用於新患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2664347855","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664347855?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:15","pubTimestamp":1788261324,"startTime":"0","endTime":"0","summary":"英国监管机构因数据不可靠,暂停安进公司Tavneos用于新患者路透9月1日-英国药品监管机构周二暂停了安进公司旗下AMGN.O研发的罕见病药物Tavneos对新患者的使用和销售,称支持该药获批的主要研究结果不可靠。监管机构表示,由于主要临床试验的数据不可靠,该研究已无法证明该药有效,也无法证明其益处大于风险。Tavneos由ChemoCentryx公司研发,安进公司于2022年以37亿美元收购了该公司。欧洲委员会于8月撤销了Tavneos的批准,此前监管机构发现其关键试验数据不可靠。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4T44T10B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","LU0058720904.USD","LU0889565916.HKD","LU2242646821.SGD","IE0002141913.USD","LU0868494617.USD","BK4581","LU1571399168.USD","LU2089984988.USD","BK7508","IBBQ","LU2112291526.USD","BK4139","IE00BJT1NW94.SGD","LU1023059063.AUD","IBB","LU1983299246.USD","LU0289739699.SGD","LU0122379950.USD","TBXU","SG9999001440.SGD","BK4588","LU1061106388.HKD","CSL.AU","IE00B2B36J28.USD","PBE","BK4533","IE00BJJMRZ35.SGD","BK7067","LU2242652126.USD","LU2468319806.SGD","BK7511","AMGN","BIB","IE00BFTCPJ56.SGD","PJP","LU1057294990.SGD","BBH","LU0320765992.SGD","BK7501","LU0109394709.USD","BK4534","BK4585","BK4566","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148791645","title":"英國藥品與健康產品管理局:通知上市許可持有方,自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor","url":"https://stock-news.laohu8.com/highlight/detail?id=1148791645","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148791645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 17:35","pubTimestamp":1788255329,"startTime":"0","endTime":"0","summary":"英国药品与健康产品管理局(MHRA)已正式告知上市许可持有方,关于暂停Avacopan Vifor用于新患者的使用、供应及销售的相关决定。该措施自9月1日起生效。此番调整涉及该药物的市场流通环节,意在规范其临床应用范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","BK4581","PJP","BK4599","LU1571399168.USD","TBXU","IE0002141913.USD","BBH","LU0889565916.HKD","LU2468319806.SGD","IBB","BK4585","PBE","LU0868494617.USD","SG9999001440.SGD","LU1983299246.USD","LU1061106388.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4534","LU2242652126.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","BK4139","LU1023059063.AUD","IE00BJT1NW94.SGD","IBBQ","LU2089984988.USD","BK4588","AMGN","LU0320765992.SGD","BIB","BK4566","LU0122379950.USD","BK4533","LU0058720904.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002674","title":"特朗普政府將宣佈藥品定價協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002674","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002674?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 00:07","pubTimestamp":1788192474,"startTime":"0","endTime":"0","summary":"特朗普政府将宣布药品定价协议预计拜耳、武田、CSL以及中型生物技术公司将达成新协议路透此前曾报导,小型制药商认为参与其中的财务激励有限美国处方药价格往往是其他发达国家的近三倍路透8月31日-白宫一名官员表示,美国总统唐纳德·特朗普 预计将于周一宣布新一轮药品定价协议,这是旨在降低美国民众医疗保健成本举措的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4T44S1CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU1868837136.USD","LU2750360641.GBP","THNR","OZEM","IBBQ","BK7508","LU2361044949.HKD","GB00BDT5M118.USD","LU2746668974.SGD","MEDI","SG9999013999.USD","IE00B2B36J28.USD","LU0198837287.USD","SGXZ99366536.SGD","BK4139","ILDR","SG9999014880.SGD","LU0432979614.USD","LU0320765059.SGD","LU0385154629.USD","LU1035775433.USD","LU2417539215.USD","SG9999001176.USD","IXJ","LU2471134796.USD","LU1066051498.USD","IE00BJJMRY28.SGD","LU0170899867.USD","LU2462591350.SGD","LU0079474960.USD","LU2089984988.USD","LU0320765992.SGD","SG9999015978.USD","LU0266013472.USD","LU0225283273.USD","BK4516","LU1691799644.USD","LU2361044865.SGD","LU2552382058.USD","LU1548497426.USD","LU1061106388.HKD","LU2360106947.USD","LU0353189763.USD","LU1291159041.SGD","LU2265009873.SGD","SG9999014906.USD","LU1720051017.SGD","LLYZ","LU2028103732.USD","LU2168564222.USD","IE0002141913.USD","LU1868836757.USD","LU2213496289.HKD","LU0823434583.USD","LU1868836914.USD","CURE","IE00B1XK9C88.USD","LU2746668461.USD","LU0787776722.HKD","LU1145028129.USD","LU0210536198.USD","LU0203202063.USD","LU0256863811.USD","LU2324357040.USD","LU2552382132.HKD","SG9999011175.SGD","BK4581","LLYX","LU1093756168.USD","IE00B4JS1V06.HKD","LU2023250504.SGD","LU1983299246.USD","LLII","BK4533","IE0004445015.USD","LU1093756325.SGD","LU2236285917.USD","LU2602419157.SGD","LU0106261372.USD","LU2106854487.HKD","IE0002270589.USD","LU1023059063.AUD","LU0353189680.USD","SG9999014914.USD","BK7511","LU1989771016.USD","LU0097036916.USD","BK4566","LU0689472784.USD","LU1069344957.HKD","LU0708995401.HKD","LU1571399168.USD","LU1883839398.USD","IE000M9KFDE8.USD","LU0820561909.HKD","SG9999002232.USD","LU0672654240.SGD","IE00B7KXQ091.USD","LU0466842654.USD","LU0234572021.USD","CANC","IE0004445239.USD","IE00B4R5TH58.HKD","LU2063271972.USD","LU0225771236.USD","LU2111349929.HKD","CSL.AU","LU0786609619.USD","SG9999001440.SGD","SG9999015945.SGD","PJP","SGXZ57979304.SGD","IE00BJJMRX11.SGD","SG9999003800.SGD","IE00BFSS8Q28.SGD","LU2023250330.USD","LU2471134952.CNY","RXL","BK7501","LU0882574139.USD","LU1280957306.USD","LU1814569148.SGD","LU0417517546.SGD","IE00B3T34201.USD","FHLC","ELIS","LU0471298777.SGD","PBE","IE00BJT1NW94.SGD","SG9999017495.SGD","LU0061475181.USD","SG9999015952.SGD","LU0133085943.USD","LU2112291526.USD","TMED","SG9999015986.USD","IE00BLSP4239.USD","BBH","LU1064131342.USD","LU1868837300.USD","LU2168563687.JPY","BK4599","BK4550","LU0158827948.USD","LU1712237335.SGD","MHIP","LU0889565916.HKD","LU2896262040.SGD","04332","IE00BWXC8680.SGD","IE00BJJMRZ35.SGD","LU0321505868.SGD","LU2168564065.EUR","LU2468319806.SGD","LU0868494617.USD","LU2491049909.HKD","IONS","IE00BBT3K403.USD","LU0203201768.USD","LU2089284900.SGD","LU0323591593.USD","SG9999001176.SGD","LU1366192091.USD","LU2237438978.USD","BK4585","LU2271345857.HKD","LU2756315664.SGD","IE0009355771.USD","SG9999018865.SGD","LU0321505439.SGD","LU0820561818.USD","LU1057294990.SGD","IYH","LU2242646821.SGD","BK4568","LU2456880835.USD","LU0964807845.USD","LU1974910355.USD","LU0823416689.USD","LU0114720955.EUR","LU1868836591.USD","SGXZ51526630.SGD","LU0158827781.USD","LU1804176565.USD","LU2242652126.USD","LU2264538146.SGD","LU2237443622.USD","SGXZ31699556.SGD","LU2471134523.USD","LU0094547139.USD","LU0306807586.USD","LU2089283258.USD","LU1979441026.SGD","PFE","XLV","LU0354030511.USD","LU2491050071.SGD","LU0943347566.SGD","VHT","LU0985481810.HKD","BK4534","ELIL","IE00BN29S564.USD","LU0225284248.USD","LU1917777945.USD","SG9999002224.SGD","LU2211815571.USD","LU0823434740.USD","BK7067","HRTS","IE00B19Z3B42.SGD","PPH","LU2168564149.EUR","LU0316494557.USD","LU2237443549.SGD","LU2596442595.SGD","LU1127390331.HKD","LU0345770993.USD","LU1988902786.USD","IE00BKDWB100.SGD","LU0174119429.USD","LU0256863902.USD","LU2108987350.USD","LU0354030438.USD","LU0820562030.AUD","LU2462157665.USD","IE0005OL40V9.USD","LU0345770308.USD","LU0109394709.USD","LU1267930730.SGD","LU0109391861.USD","LU0306806265.USD","BK4588","AGNG","LU0683600562.USD","IE00B775H168.HKD","IE00BLSP4452.SGD","IBB","IE00BJLML261.HKD","LU1551013342.USD","LLY","AMGN","BK4007","LU0289739699.SGD","LU1894683348.USD","LU0456855351.SGD","LU2361045086.USD","SG9999018857.SGD","LU0122379950.USD","LU1623119135.USD","IHE","GDOC","LU2023251221.USD","IE00BKPKM429.USD","LU2357305700.SGD","LU2461242641.AUD","LU2491050154.USD","LU2552382215.SGD","SGXZ81514606.USD","TBXU","IE00B19Z3581.USD","LU1066053197.SGD","LU1232071149.USD","LU2750360997.AUD","IE00BFTCPJ56.SGD","LU2237443895.HKD","IE0001KFT4U8.USD","IE00BK4W5L77.USD","LU0471298694.HKD","JDOC","LU2168564495.EUR","LU1894683264.USD","LU1720051108.HKD","SG9999014898.SGD","LU2237443382.USD","IE00BFSS7M15.SGD","IE00BK4W5M84.HKD","LU0238689110.USD","BIB","LU2087625088.SGD","LU0096364046.USD","LU2237443465.HKD","LU2237443978.SGD","LU0640476718.USD","WDNA","FTXH","LU2756315318.SGD","LU0882574055.USD","IE00B1BXHZ80.USD","LU1323610961.USD","BK4592","LU2471134879.HKD","TRUH","LU0058720904.USD","MEDX","LU1551013425.SGD","LU1629891620.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017770","title":"機構:爭奪天然氣資產推高併購交易規模創2013年以來新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017770","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017770?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 22:52","pubTimestamp":1788187964,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AAUM","ACTV","IEO","FFSM","TMED","FTXN","GUSH","DBC","BK4585","IYH","VXF","PSP","DUG","BOIL","GTPE","MNA","FCG","CANC","RSPH","ERX","PEVC","IEFN","DRIP","USE","DIG","PXJ","RFG","UYG","BK4588","KOLD","XLFI","DFMC","BK4570","XES","IBBQ","DBE","PBPH","PXE","MMID","IXC","DRLL","XOP","PRVT","WTIU","VDE","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663778550","title":"安進(AMGN)降脂藥Repatha新臨床數據:可降低未發生心梗或中風高危患者20%死亡風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2663778550","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663778550?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:48","pubTimestamp":1788173287,"startTime":"0","endTime":"0","summary":"研究结果显示,对于既往未发生过心肌梗死或中风的高危成年患者,在接受他汀类或其他降脂疗法的基础上加用Repatha,可显著降低20%的全因死亡风险,同时有效降低心血管死亡率。数据显示,Repatha能在治疗开启最早6个月内降低心梗风险,且将患者低密度脂蛋白胆固醇中位数降低至45mg/dL,远优于安慰剂组的109mg/dL。此外,欧盟委员会已于2026年8月批准扩大Repatha在欧洲的适应症,用于确诊或高危确诊的动脉粥样硬化性心血管疾病成年患者降低心血管风险。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305491","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU1983299246.USD","AMGN","BK4581","LU2468319806.SGD","LU2242646821.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE0002141913.USD","LU1057294990.SGD","LU2089984988.USD","LU2112291526.USD","BIB","BK4588","LU2242652126.USD","LU1061106388.HKD","BK4566","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0058720904.USD","LU1571399168.USD","IBB","PBE","PJP","IBBQ","BBH","TBXU","IE00BJT1NW94.SGD","BK4139","LU0868494617.USD","LU1023059063.AUD","SG9999001440.SGD","BK4534","BK4599","LU0109394709.USD","LU0122379950.USD","BK4533","IE0009355771.USD","BK4585","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662091790","title":"南京諾令生物科技股份有限公司向港交所提交上市申請書,獨家保薦人為建銀國際。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662091790","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662091790?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 22:53","pubTimestamp":1787928801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TBXU","BIOY","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662942093","title":"據港交所文件,維眸生物科技股份有限公司-B向港交所提交上市申請書。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662942093","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662942093?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 20:52","pubTimestamp":1787921537,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TBXU","BIOY","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036374","title":"美國食品藥品監督管理局(FDA)批准吉利德治療艾滋病的每日一次複方片劑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036374","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036374?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867453,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)批准吉利德治疗艾滋病的每日一次复方片剂路透8月27日-吉利德科学公司周四表示,美国食品和药物管理局已批准该公司研发的每日一次口服复方药GILD.O,用于治疗HIV病毒载量已降至极低水平的成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4S44O24V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","TBXU","IBBQ","LU0109394709.USD","LU1037948541.HKD","BIB","BK4139","SG9999015945.SGD","LU0289739699.SGD","BK4583","BK4585","LU1023059063.AUD","LU1571399168.USD","IE00B7SZLL34.SGD","IE0002270589.USD","BK4568","LU1934455194.USD","IE00BKVL7J92.USD","LU0889565916.HKD","LU1037948897.HKD","LU2112291526.USD","BMED","LU2324357040.USD","BK4566","LU2468319806.SGD","LU1934455277.USD","SG9999015986.USD","BK4532","IE00BZ1G4Q59.USD","SG9999015978.USD","LU0058720904.USD","IBB","LU1674673691.USD","LU0965509101.SGD","BBH","LU0861579265.USD","SG9999015952.SGD","LU1839511570.USD","LU0823416689.USD","LU1430594728.SGD","LU0114720955.EUR","LU0965508806.USD","LU0965509283.SGD","TMED","LU1066053197.SGD","IE00B19Z3581.USD","GILD","MEDI","LU1778281490.HKD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198194055","title":"美國FDA批准吉利德科學Bixlenvo™上市:每日單片方案為病毒學抑制HIV成人患者提供新選擇,涵蓋複雜治療方案人群","url":"https://stock-news.laohu8.com/highlight/detail?id=1198194055","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198194055?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:49","pubTimestamp":1787867358,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准了吉利德科学旗下新药Bixlenvo。这款每日一次的单片制剂,专为病毒学抑制状态的HIV成人感染者设计——即便是那些正在接受复杂治疗方案的病患,也适用这一新选项。此项获批标志着HIV治疗领域又添一枚重要砝码。Bixlenvo以单片复方形式呈现,将给药频率与用药负担同步压缩,患者无需再面对繁琐的多药组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","LU0889565916.HKD","LU2112291526.USD","LU1674673428.USD","LU0965509101.SGD","BK4588","LU0823416689.USD","IE00B19Z3581.USD","LU1585245621.USD","IE00BSNM7G36.USD","SG9999015952.SGD","BK4578","BK4583","IBB","LU1023059063.AUD","LU2324357040.USD","LU2468319806.SGD","LU1674673691.USD","BK4566","LU2357627491.SGD","IE00BZ1G4Q59.USD","MEDI","SG9999015986.USD","LU1066051498.USD","BK4568","LU0109394709.USD","LU0289739699.SGD","LU1061106388.HKD","LU2087621335.USD","LU0965509010.AUD","LU2089984988.USD","LU0965509283.SGD","IE00BKVL7J92.USD","BBH","IE00B7SZLL34.SGD","IBBQ","LU0114720955.EUR","LU1057294990.SGD","SG9999015978.USD","IE00B19Z3B42.SGD","BK4550","TBXU","LU0234570918.USD","IE00B3T34201.USD","BIB","LU0859254822.USD","IE0002270589.USD","BMED","BK4139","BK4585","LU0320765992.SGD","LU1934455863.HKD","LU1778281490.HKD","SG9999015945.SGD","LU0122379950.USD","LU1934455277.USD","LU1571399168.USD","LU1839511570.USD","LU1066053197.SGD","LU1934455194.USD","LU1037948897.HKD","TMED","LU0861579265.USD","LU1430594728.SGD","BK4532","LU0058720904.USD","LU1037948541.HKD","LU0882574055.USD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775484","title":"英國股市——8月27日需關注的因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775484","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:53","pubTimestamp":1787813617,"startTime":"0","endTime":"0","summary":"更新 1-英国股市——8月27日需关注的因素新增新闻报导,更新期货行情路透8月27日-预计周四英国富时100指数.FTSE将低开,期货FFIc1下跌0.4%。*7月汽车产量:行业数据显示,受出口疲软及部分工厂提前进行夏季检修停产影响,英国7月汽车产量 同比下降11.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345780950.USD","GLEN.UK","BIB","IBBQ","LU0949170426.SGD","LU1057294990.SGD","LU0553294199.USD","BK5105","LU1880407132.USD","PJP","SGXZ57979304.SGD","LU0868494617.USD","CRDA.UK","HFD.UK","LU0889565916.HKD","IBB","TBXU","LU0310800379.SGD","BBH","LU1267930227.SGD","BK4585","IE0034235188.USD","LU0211326755.USD","LU1267930573.SGD","LU0171276677.USD","LU0345777147.USD","PBE","PRU.UK","SG9999001176.SGD","LU0122379950.USD","GAW.UK","LU1355424745.HKD","AZN.UK","PPH.UK","LU0047713382.USD","LU0857590862.USD","LU1119994496.HKD","LU2089984988.USD","03165","LU0171293334.USD","LU0969580561.USD","LU0963555726.SGD","LU1989771016.USD","LU1104425308.USD","LU2293690082.USD","LU0075056555.USD","BK4139","LU0792757196.USD","LU1989772923.USD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639773","title":"阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639773","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662639773?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:08","pubTimestamp":1787810905,"startTime":"0","endTime":"0","summary":"阿斯利康的哮喘药物Tezspire在食管炎晚期临床试验中达到了所有目标路透8月27日-阿斯利康(AstraZeneca)AZN.L周四表示,其与安进(Amgen)AMGN.O联合开发的哮喘药物Tezspire,在治疗嗜酸性粒细胞性食管炎(一种食管的慢性炎症性疾病)的晚期临床试验中达到了主要和次要研究目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU0171276677.USD","LU0640478417.SGD","PBE","LU1196032939.SGD","LU0390134368.USD","TBXU","BBH","LU0158827948.USD","LU0211328371.USD","LU0757432116.USD","LU0496365809.HKD","BK4588","AMGN","IBB","LU0203345920.USD","PJP","LU1015430645.USD","LU1064927863.SGD","IE00B2B36J28.USD","BK4139","LU1481599808.USD","LU2089284900.SGD","BK5011","LU1273509221.SGD","LU0823416689.USD","LU0889565916.HKD","LU2237443549.SGD","LU0882574055.USD","LU2357627491.SGD","LU1989772840.SGD","LU0949170426.SGD","LU1061106388.HKD","LU1323610961.USD","LU0011850046.USD","03165","LU1119994496.HKD","IBBQ","LU2125909247.SGD","AZN.UK","LU0557290698.USD","LU0211327993.USD","BIB","LU1261432733.SGD","BK4599","LU0960981461.USD","LU0432979614.USD","LU1267930813.SGD","LU1923622614.USD","LU0526926950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146489142","title":"Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果,共同主要終點及所有關鍵次要終點全面達標","url":"https://stock-news.laohu8.com/highlight/detail?id=1146489142","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146489142?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810443,"startTime":"0","endTime":"0","summary":"Tezspire在针对嗜酸性食管炎的III期临床试验中取得了令人瞩目的积极结果。该试验不仅成功达到了共同主要终点,而且所有关键次要终点也悉数告捷。Tezspire的优异表现,标志着该领域治疗可能迎来重大变革。共同主要终点的同时达成,以及关键次要终点的全面覆盖,充分验证了Tezspire的疗效一致性和临床获益的广泛性。业内专家指出,Tezspire的这项研究成果,不仅巩固了其在炎症性疾病治疗领域的地位,更可能为后续的监管审批和市场推广奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU0868494617.USD","BK4139","LU1571399168.USD","IE00BJT1NW94.SGD","TBXU","LU1983299246.USD","LU0289739699.SGD","BK4533","IE00BFTCPJ56.SGD","BBH","BIB","BK4534","IE00B4R5TH58.HKD","LU0122379950.USD","IE0002141913.USD","LU2089984988.USD","PBE","BK4566","IBB","BK4599","IBBQ","IE00B2B36J28.USD","LU0320765992.SGD","IE0009355771.USD","BK4585","SG9999001440.SGD","LU1057294990.SGD","LU0889565916.HKD","LU2112291526.USD","LU2242652126.USD","LU2242646821.SGD","BK4588","PJP","LU0109394709.USD","BK4581","LU0058720904.USD","LU2468319806.SGD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106797728","title":"美股開盤|三大指數升跌不一;Meta升逾3%、小鵬汽車升逾3%;生物科技股活躍","url":"https://stock-news.laohu8.com/highlight/detail?id=1106797728","media":"美股开盘","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106797728?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 21:30","pubTimestamp":1787751055,"startTime":"0","endTime":"0","summary":"投资者在英伟达财报公布前保持观望,市场情绪较为谨慎。公司拟通过部分赔偿及功能调整降低监管不确定性,股价盘前显著反弹。美国第二季度实际GDP年化季率维持1.5%。美国7月核心PCE同比增长3.3%,通胀黏性仍存。管理层警示激烈竞争对利润率造成压力,股价盘后回落近4%。营收及利润双双下滑,显示美国消费者支出放缓。公司宣称AI可服务的潜在市场规模高达30万亿美元,市场热议其估值合理性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09868","BIOY","BK4555","XPEG","BK1575","BK1610","BK4551","BK1588","TBXU","BK4099","BK4526","XPEV","BK4505","BK1539","BK1587","EVS.SI","BK1119","LU0593848301.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662784028","title":"羅兵咸永道:上半年中國併購交易量7316宗創歷史新高 預計下半年延續強勁勢頭","url":"https://stock-news.laohu8.com/highlight/detail?id=2662784028","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662784028?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 16:00","pubTimestamp":1787644859,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,普华永道指出,今年上半年,中国并购交易数量达7316宗,同比增加近30%,创下历史新高;交易总额同比增长56%至2416亿美元,为2023年以来最佳半年度表现。普华永道交易服务税务主管合伙人梅梁表示,预期中国并购市场在2026年下半年将延续强劲势头,全年交易总额有望实现同比增长。港交所仅上半年即录得51宗具私募股权背景的IPO,创下同期历史新高,超过半数为高科技企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FFSM","RSPH","IEFN","MMID","ACTV","BK4585","IBBQ","IYH","MNA","BK4588","RFG","PBPH","PSP","UYG","GTPE","PRVT","XLFI","TMED","PEVC","CANC","DFMC","VXF","AAUM","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍,覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定,将吉利德科学(Gilead Sciences)旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域,且不再受限于患者的PD-L1表达状态。这一举措意味着,无论生物标志物检测结果如何,符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择,也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应,认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","LU1839511570.USD","GILD","LU1037948541.HKD","IE0002270589.USD","LU2357627491.SGD","LU2089984988.USD","LU1037948897.HKD","LU0889565916.HKD","BK4532","LU0289739699.SGD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1023059063.AUD","LU0058720904.USD","LU0823416689.USD","SG9999015945.SGD","LU2087621335.USD","BK4578","BK4585","LU0861579265.USD","TBXU","IE00B3T34201.USD","LU0859254822.USD","BBH","LU1430594728.SGD","LU1934455863.HKD","LU2324357040.USD","BK4139","IE00BSNM7G36.USD","LU0882574055.USD","LU1066051498.USD","LU0234570918.USD","IBBQ","IE00B7SZLL34.SGD","BK4583","BMED","LU2112291526.USD","BK4566","BIB","LU0965508806.USD","LU0965509101.SGD","BK4550","IE00B19Z3581.USD","LU1778281490.HKD","LU1057294990.SGD","LU1934455194.USD","LU1066053197.SGD","IE00BKVL7J92.USD","LU0109394709.USD","LU0965509010.AUD","SG9999015978.USD","LU0114720955.EUR","SG9999015952.SGD","IE00BZ1G4Q59.USD","BK4568","LU1674673428.USD","MEDI","IBB","LU0122379950.USD","BK4588","LU1571399168.USD","LU1585245621.USD","LU1934455277.USD","LU1674673691.USD","LU2468319806.SGD","SG9999015986.USD","TMED","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科學:歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布,欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步,为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","IE0002270589.USD","BK4578","LU1430594728.SGD","LU0109394709.USD","LU0289739699.SGD","LU1585245621.USD","LU1934455194.USD","LU2468319806.SGD","SG9999015952.SGD","SG9999015986.USD","BMED","LU2089984988.USD","LU2357627491.SGD","LU1839511570.USD","BIB","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU2112291526.USD","IE00BKVL7J92.USD","LU1037948541.HKD","IE00B19Z3B42.SGD","BK4583","LU1061106388.HKD","LU0234570918.USD","BBH","LU0320765992.SGD","TBXU","LU1934455863.HKD","MEDI","BK4532","LU1934455277.USD","LU1674673428.USD","LU0859254822.USD","LU0882574055.USD","BK4585","LU1066053197.SGD","GILD","IBB","BK4568","TMED","BK4139","IBBQ","IE00B7SZLL34.SGD","LU0889565916.HKD","LU1037948897.HKD","LU0823416689.USD","LU0965509283.SGD","LU1674673691.USD","LU0114720955.EUR","LU1023059063.AUD","LU1066051498.USD","LU0965509101.SGD","LU1571399168.USD","LU1057294990.SGD","IE00BSNM7G36.USD","LU0058720904.USD","BK4550","BK4566","LU1778281490.HKD","LU0122379950.USD","LU0861579265.USD","LU2087621335.USD","LU2324357040.USD","SG9999015945.SGD","IE00B19Z3581.USD","LU0965508806.USD","IE00B3T34201.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291370","title":"美國聯邦貿易委員會(FTC):安進專利申請收購交易受到反壟斷審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:49","pubTimestamp":1787327356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PJP","RSPT","DISC","LRGG","TBXU","QQMG","GXPC","EMQQ","BIB","BUYO","IXP","BBH","ARB","BCTK","MRGR","NBDS","ORCZ","FCOM","BWEB","TRUC","EVNT","ONEQ","FTC","WEBL","MSFX","HCA","MUSQ","PBE","GXPT","IBBQ","XLCI","JHMT","GOOX","IEME","IHF","IBB","PBS","MNA","TGRW","WEBX","CWC","AMGN","NBCC","TDAQ","JHCS","DRUP","MSFY","PNQI","KEMQ","GGTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250489","title":"Piper Sandler上調安進目標價至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBH","LU0320765992.SGD","LU2242652126.USD","IE0002141913.USD","BK4599","LU0109394709.USD","PJP","BK4534","BK4566","PBE","AMGN","LU1571399168.USD","BK4588","LU1061106388.HKD","LU0122379950.USD","LU1983299246.USD","LU1057294990.SGD","SG9999001440.SGD","IBB","LU2468319806.SGD","LU0058720904.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","BIB","BK4533","BK4585","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU2112291526.USD","LU1023059063.AUD","TBXU","IBBQ","BK4139","LU0289739699.SGD","UDN","UUP","BK4581","LU2242646821.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043834","title":"美國研究綜述-安進、Analog Devices、莫德納","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043834","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660043834?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:49","pubTimestamp":1787212153,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Analog Devices、莫德纳路透8月20日-周四,华尔街证券分析师上调了多家在美国上市公司的评级和目标股价,其中包括安进、模拟设备公司和莫德纳。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4S44H0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU1720051017.SGD","BK4599","IBB","LU0203345920.USD","LU1989764664.SGD","BK4130","LU1978683503.SGD","LU2506952097.USD","LU1585245621.USD","LU2129689431.USD","LU1989764748.USD","BK4512","IE00B5TLWC47.USD","LU0210528500.USD","BK4588","LU0128525929.USD","LU1804176565.USD","LU1116320737.USD","BK4534","LU0314104364.USD","LU0786609619.USD","LU1430594728.SGD","LU0417517546.SGD","LU0320765646.SGD","LU0472753341.HKD","IYH","HCA","IE00B4R5TH58.HKD","IE00BMPRXR70.SGD","LU1169590202.USD","LU1261432733.SGD","LU0950375773.USD","LU0211331839.USD","SG9999015945.SGD","LU0545039389.USD","IE00BJT1NW94.SGD","LU1066051225.USD","LU0432979614.USD","LU0109394709.USD","LU0130517989.USD","LU0511384066.AUD","LU2237438978.USD","LU1150488135.SGD","LU1989773731.SGD","LU2517655374.HKD","LU1244550577.SGD","LU2244417387.USD","LU1267930490.SGD","LU2272731782.SGD","BK4504","LU0170899867.USD","IE00B19Z9P08.USD","LU0823417653.USD","LU0289739343.SGD","PAWZ","LU0868494617.USD","LU0859254822.USD","IE000M9KFDE8.USD","LU0052756011.USD","LU2242652126.USD","LU0985320562.USD","FAI","LU0203347892.USD","PBE","IE000MB6IJN5.SGD","BK4535","BK4155","LU2347655156.SGD","SG9999015341.SGD","XLV","BK4554","LU1551013342.USD","LU2458330243.SGD","IE0004445239.USD","MRVX","LU2272731865.HKD","LU2360032135.SGD","BK4613","IXJ","LU0130102774.USD","SG9999000418.SGD","LU2106854487.HKD","LU2491049909.HKD","SG9999014021.USD","LGHT","BK4605","BK4581","LU1670711040.USD","IGV","LU0965509010.AUD","LU1923622291.USD","LU0719512351.SGD","WOLF","SG9999001176.USD","IE0002141913.USD","LU0314106906.USD","LU2275660780.HKD","LU0274383776.USD","LU0823434740.USD","LU2491050071.SGD","MRNY","LU1934455863.HKD","WUGI","CIBR","SOXY","BK4558","TJX","LU1803068979.SGD","MRVL","BK4516","IE00B19Z3B42.SGD","LU0289961442.SGD","IHE","LU2404859741.USD","BK4094","LU2361044865.SGD","LU1074936037.SGD","LU0878866978.SGD","LU2543165471.USD","LU2125909593.SGD","SPAM","IE00BVYPNV92.GBP","LU0029864427.USD","LU1506573853.SGD","CLOD","SG9999014567.USD","LU0266013472.USD","LU1989772923.USD","LU1699723380.USD","LU0444973449.USD","LU0965508806.USD","BK4559","BK4023","LU1489326972.SGD","LU2023250843.SGD","IE000WAW04H5.SGD","LU0077335932.USD","LU0057025933.USD","IE0009356076.USD","IE0004091025.USD","LU1691799644.USD","SG9999015978.USD","WISE","SG9999015358.SGD","LU1674673428.USD","LU2125909759.SGD","LU0868494708.USD","DAT","BK4183","HRTS","LU0097036916.USD","LU2361044949.HKD","LU0795875086.SGD","BK4598","ADI","LU2322448791.USD","SNOW","LU2089984988.USD","IE000F7OJYX1.SGD","IE0000B7K699.USD","TGT","LU1923622614.USD","LU2458330169.SGD","LU1496350502.SGD","LU0823416689.USD","LU1571399168.USD","LU2552382058.USD","LU1093756168.USD","LU0006306889.USD","LU2125909916.SGD","PJP","LU2552382215.SGD","LU2506951958.HKD","LU1712237335.SGD","IE00BZ9MQY76.HKD","LU2491050154.USD","IE00BKVL7J92.USD","BK4551","LU0444971666.USD","LU0949170772.SGD","LU0689626769.HKD","BK4528","LU2092937221.SGD","LU1267930227.SGD","SG9999001176.SGD","LU2357305700.SGD","IE00B775SV38.USD","SG9999014005.SGD","LU1861214812.USD","LU1974910355.USD","BK4604","IHF","IE00B19Z3581.USD","LU1066053197.SGD","LU2237443465.HKD","LU2360107168.USD","MRNA","LU0310800379.SGD","DTCR","FXL","LU1642822529.SGD","LU0211327993.USD","LU1935042991.SGD","BK4083","BK4597","ARTY","LU0265550946.USD","LU2360106780.USD","BIB","LU2360108059.USD","LU1023059063.AUD","TBXU","IE00BDGV0183.EUR","LU1093756325.SGD","IE00BLSP4239.USD","MRVU","RXL","SNOY","SNOU","LU1037948541.HKD","BK4116","QQQA","LU1267930573.SGD","IE00B5949003.HKD","LU0942090050.USD","LU0456855351.SGD","LU1201861249.SGD","LU0943347566.SGD","LU1670628061.USD","CRWD","BK4097","HAKY","BK4560","SG9999014575.USD","LU2041044095.USD","FDTX","SG9999014542.SGD","LU2361045086.USD","IE00BSNM7G36.USD","LU0053666078.USD","BK4501","LU2517655028.SGD","SG9999011175.SGD","LU0690374615.EUR","LU0256863902.USD","BK4503","AIS","LU0477156953.USD","LU1003077747.HKD","LU0912757837.SGD","XNTK","LU0124676726.USD","LU1989763005.USD","LU1548497426.USD","LU2931357623.SGD","LU1066051498.USD","LU0985489474.SGD","LU0106261372.USD","LU1720051108.HKD","LU0310800965.SGD","LU0882574055.USD","LU2237443895.HKD","LU0433182093.SGD","BK4007","BK4141","LU1992135399.USD","BK4185","BK4505","LU2237443622.USD","LU1941712348.USD","LU1983299246.USD","LU2517655291.USD","IE0009355771.USD","BK4561","ABBV","LU0061475181.USD","IE00BMPRXQ63.HKD","LU0965509283.SGD","WDNA","IDNA","IE00B894F039.SGD","LU2125154778.USD","MEDX","IE00BZ1G4Q59.USD","IE00BLSP4452.SGD","LU0081259029.USD","LU1852331112.SGD","IE00B1BXHZ80.USD","JDOC","LU0726765562.USD","IE0034235188.USD","AIPI","LU0265550359.USD","LU0098860793.USD","LU1670627923.USD","LU2089283258.USD","LU1066051811.HKD","LU0823411888.USD","IE00B3S45H60.SGD","FHLC","LU0302445910.USD","LU0823417737.USD","LU2133065610.SGD","LU2487616109.SGD","LU0820561818.USD","LU1929549753.HKD","LU1992135472.HKD","LU0187121727.USD","LU0980610538.SGD","LU2347655073.USD","LU0082616367.USD","LU2298322129.HKD","LU0738911758.USD","LU1988902786.USD","LU1244550221.USD","LU2506951875.HKD","LU0058720904.USD","BK4607","LU2433249047.HKD","VHT","GLAM","LU0320765992.SGD","LU0154236417.USD","BK4566","SGXZ57979304.SGD","LU0070302665.USD","IE00BFTCPJ56.SGD","MRK","04332","MVLL","LU1670710588.SGD","LU2506952170.USD","LU1496350171.SGD","LU2237443549.SGD","LU1244550494.USD","LU1917777945.USD","LU2129689514.USD","IE000BZT7R73.USD","LU2355687059.USD","BK4592","PPH","LU1046421795.USD","LU0128525689.USD","PSWD","LU1778281490.HKD","LU1674673691.USD","LU0795875169.SGD","LU0690374961.EUR","LU1923623000.USD","LU1989772840.SGD","AMGN","LU1150488218.USD","IE00BN8TJ469.HKD","TRUH","SG9999015986.USD","LU1119994496.HKD","LU2357627491.SGD","LU1861220033.SGD","LU1951198990.SGD","LU1069347547.HKD","GTEK","PCTY","CRWC","LU0724618433.USD","IE00B2B36J28.USD","BK4139","LU2125909247.SGD","LU1057294990.SGD","BK4543","BK4568","AIFD","LU2473716301.USD","BK4548","BK4596","LU0094547139.USD","IE0002270589.USD","SG9999014039.USD","XDAT","LU0889565833.HKD","LU1037948897.HKD","LU1732800096.USD","LU0127658192.USD","LU2360107325.USD","LU0823421333.USD","LU2272731600.USD","LU0234572021.USD","LU2264538146.SGD","LU1941712264.USD","SG9999003800.SGD","LU1951200564.SGD","LU2098885051.SGD","AGNG","LU1989771016.USD","LU2404859667.USD","LU0310799852.SGD","LU1303367103.USD","BK4515","GDOC","LU0320765489.SGD","MRNX","LU0861579265.USD","LU2324357040.USD","LU0889565916.HKD","WDAY","BK4585","IBBQ","LU0114720955.EUR","LU0211328371.USD","LU2023250504.SGD","GNOM","LU2237443382.USD","LU1718418525.SGD","LU1823568750.SGD","LU1316542783.SGD","BK4532","LU1861215975.USD","LU2089985449.USD","CLOU","LU1839511570.USD","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU0068578508.USD","LU0661504455.SGD","LU2290526834.HKD","LU2112291526.USD","LU1084165304.USD","LU1934455277.USD","LU1861219969.SGD","LU2552382132.HKD","LU2129689605.HKD","LU1162221912.USD","LU2286300806.USD","LU0823421416.USD","LU0158827948.USD","LU0642271901.SGD","LU2125154935.USD","LOW","IE00BMPRXN33.USD","LU0820561909.HKD","IE00B3PB1722.GBP","LU0056508442.USD","BBH","SG9999015952.SGD","LU0208291251.USD","SG9999013999.USD","LU1934455194.USD","LU0957808578.USD","LU2242646821.SGD","LU2237443978.SGD","LU2298321311.HKD","IE0004086264.USD","LU2265009873.SGD","LU0122379950.USD","CRWL","LU0312595415.SGD","LU0069063385.USD","EL","FTXH","BK4550","IE00B42XCP33.USD","LU1670710661.SGD","LU0553294199.USD","LU0648001328.SGD","LU1670711123.USD","LU1935043536.SGD","LU0289739699.SGD","LU2087621335.USD","SG9999014559.SGD","LU0238689110.USD","LU1116320901.HKD","LU1235294995.USD","LU2461242641.AUD","SG9999001440.SGD","LU0234570918.USD","LU1061106388.HKD","IE000SO60NU8.SGD","LU2322448957.HKD","LU2468319806.SGD","BUG","LU2211815571.USD","LU0256863811.USD","BK4533","LU1623119135.USD","LU1035773651.USD","LU2089284900.SGD","SG9999002232.USD","LU0476273544.USD","IE00BD6J9T35.USD","SMHX","LU1815336760.USD","IE00B19Z9Z06.USD","IE00BZ199S13.USD","IE00BVYPNW00.USD","LU0124384867.USD","LU0198837287.USD","BK4114","SG9999014013.SGD","LU0689472784.USD","LU0823434583.USD","LU1732799900.SGD","LU0395794307.EUR","LU1551013425.SGD","LU0109392836.USD","LU0965509101.SGD","LU1169589451.USD","LU1291159041.SGD","IE00BGHQF631.EUR","FTXL","LU1064131342.USD","WCBR","LU2023251221.USD","LU2250418816.HKD","LU0708994859.HKD","SG9999002224.SGD","BILL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":159,"code":"91000000","status":"200"}]}}